<DOC>
	<DOC>NCT00273481</DOC>
	<brief_summary>To compare the intraocular pressure efficacy and safety of the DTFC given twice daily versus the LTFC given once every morning following a run-in period with timolol maleate given twice daily.</brief_summary>
	<brief_title>Cosopt Versus Xalacom</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma, Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Dorzolamide</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<criteria>adults with primary openangle or pigmentdispersion glaucoma, or ocular hypertension at baseline the intraocular pressure should be 20 to 32 mm Hg inclusive at 08:00 measurement (Visit 2) after dosing with timolol the evening before the intraocular pressure should be 32 mm Hg or less at all the time points in both eyes at Visit 2 visual acuity should be 6/60 or better in the study eye(s) any anticipated change in systemic hypotensive therapy during the trial use of any corticosteroids by any route for more than two weeks during the study contraindications to study medicines</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
</DOC>